![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 ASFOTASE ALFA (8)
02 BETRIXABAN (2)
03 DANICOPAN (2)
04 ECULIZUMAB (2)
05 RAVULIZUMAB (3)
06 RAVULIZUMAB-CWVZ (1)
07 SEBELIPASE ALFA (2)
08 Selumetinib Sulfate (2)
09 asfotas alpha (2)
10 eculizumab (12)
11 ekulizumab (1)
12 ravulizumab (16)
13 sebelipas alpha (1)
01 ALEXION PHARM (7)
02 ALEXION PHARMA GMBH (9)
03 ALEXION PHARMS INC (2)
04 Alexion Europe SAS, (4)
05 Alexion Pharmaceuticals (2)
06 Alexion Pharmaceuticals Australasia Pty Ltd (28)
07 PORTOLA PHARMS INC (2)
01 CAPSULE (2)
02 CAPSULE;ORAL (2)
03 CONCENTRATE FOR SOLUTION FOR INFUSION (2)
04 INJECTABLE; IV (INFUSION) (1)
05 INJECTABLE;INJECTION (2)
06 SOLUTION (9)
07 SOLUTION FOR INJECTION (2)
08 SOLUTION;INJECTION (4)
09 TABLET;ORAL (2)
10 Blank (28)
01 10 MG / ML (1)
02 100 MG / ML (1)
03 100MG (1)
04 100MG/ML (1)
05 10MG (1)
06 10MG/ML (2)
07 1100MG/11ML (1)
08 18MG/0.45ML (1)
09 2 MG / ML (1)
10 20MG/10ML (1)
11 25MG (1)
12 28MG/0.7ML (1)
13 2MG/ML (1)
14 300MG (1)
15 300MG/30ML(10MG/ML) (1)
16 300MG/3ML (1)
17 40 MG / ML (1)
18 40MG (1)
19 40MG/ML (4)
20 50MG (1)
21 80MG (1)
22 80MG/0.8ML (1)
23 Blank (28)
01 Australia (28)
02 Canada (11)
03 Sweden (4)
04 USA (11)